Skip to main content

Table 2 Indicators for quantity and quality of antibiotics use in internal medicine and ICU patients

From: A comprehensive point prevalence survey of the quality and quantity of antimicrobial use in Chinese general hospitals and clinical specialties

Items

Internal medicine

ICU

ID

Pulm

Hema

Onco

Endo

Neur

Ne-Rh

other

Total

Prescriptions (n)

339

1395

419

160

30

37

55

52

2487

675

Antibiotics use rate (%)

60.4

72.78

32.31

12.31

13.68

8.26

22.77

39.81

38.79

66.27

Antibiotics use indication (%)

With

90.86

98.64

96.66

95.82

100

91.89

96.36

98.08

96.90

95.41

Without

9.14

1.36

3.36

4.38

 

8.11

3.64

1.92

3.10

4.59

Therapeutics (%)

Empiric

79.06

93.26

85.68

83.12

96.67

62.16

65.45

90.38

88.30

69.13

Targeted

9.14

3.66

10.02

11.25

3.33

37.84

29.09

3.85

7.04

22.92

Unknown

11.80

3.08

4.30

5.62

  

5.45

5.77

4.66

7.94

AUI (DDDs/100 patient.day)

113.97

131.43

63.09

14.41

27.12

11.86

24.27

42.72

67.79

124.45

Guidelines (%)

Complied

83.78

88.17

93.56

78.12

73.33

91.89

89.09

88.46

87.74

81.63

Non-complied

4.13

6.16

0.48

9.38

20.00

5.41

1.82

 

5.07

6.96

Unavailable

 

2.01

1.19

3.12

3.33

2.70

 

3.85

1.69

4.59

No guideline

 

0.50

0.48

2.50

   

1.92

0.56

 

Unknown

12.09

3.16

4.30

6.88

3.33

 

9.09

5.77

4.95

6.81

Therapy referring to biomarkers (%)

37.46

48.39

34.84

47.50

10.00

21.62

20.00

34.62

42.78

18.05

 

Prescription reason recorded (%)

14.45

5.30

11.22

13.75

10.00

13.51

10.91

7.69

8.44

29.93

Therapeutic duration up to PPS (d)

 ≤ 3

27.73

32.11

29.59

38.75

26.67

24.32

25.45

51.92

31.60

31.59

4–7

30.68

32.04

40.10

28.75

46.47

45.95

36.36

26.92

33.37

31.76

8–14

13.57

21.08

20.53

15.00

23.33

24.32

30.91

21.15

19.86

22.75

 ≥ 15

18.58

13.12

7.16

10.00

 

2.70

  

11.78

7.22

Unknown

9.44

1.65

2.63

7.50

3.33

2.70

7.27

 

3.38

6.68

Administrative route (%)

Intravenous

82.01

94.06

85.20

92.64

93.33

91.89

87.27

96.08

90.69

90.71

Oral

14.45

3.51

11.22

4.29

3.33

5.41

5.45

1.96

6.38

2.65

Others

 

0.07

0.24

    

1.96

0.12

0.17

Unknown

3.54

2.36

3.34

3.07

3.33

2.70

7.27

 

2.81

6.47

Combinatory use (%)

Single

58.96

59.06

55.13

77.86

84.62

76.67

80.43

81.82

61.74

57.97

2 drugs

30.66

37.92

33.46

20.62

15.38

23.33

19.57

18.18

33.41

33.42

 ≥ 3 drugs

10.38

3.03

11.41

1.52

    

4.85

8.61

Review or stop recorded (%)

51.62

26.74

43.44

46.88

46.67

32.43

56.36

9.62

34.86

44.98

  1. ID Infectious disease; Pulm Pulmonary department; Hema Hematology department; Onco Oncology department; Endo Endocrinology department; Neur Neurology department; Ne-Rh Nephrology & Rheumatology department; ICU Intensive care unit; RTI Respiratory tract infections; NA Non-applicable; FN Fever with neutropenic; FUO Fever unknown origin; MP Medicine prophylaxis; GI/IA, Gastroenterological infection and intra-abdominal infection; SST/BJ Skin and skin structure, and bone and joint infections; UTI Urinary tract infection; AUI Antibiotic use intensity
Back to article page

Antimicrobial Resistance & Infection Control

ISSN: 2047-2994

Contact us